发明名称 |
PHARMACEUTICAL COMPOSITION |
摘要 |
FIELD: medicine, endocrinology, pharmacy. ^ SUBSTANCE: invention relates to treatment of diabetes mellitus and complications associated with diabetes mellitus. Invention proposes using a pharmaceutical composition for prophylaxis and treatment of diabetes mellitus and associated complications. Pharmaceutical composition comprises an enhancer for sensitivity to insulin (but excluding troglitazone) in combination with at least component from group consisting of aldose reductase inhibitor, biguanide, statin compound and angiotensin-converting enzyme inhibitor. Proposed pharmaceutical composition offers the strong inhibitory effect with respect to diabetic hyperglycemia. ^ EFFECT: valuable medicinal properties of pharmaceutical composition. ^ 30 cl |
申请公布号 |
RU2323004(C2) |
申请公布日期 |
2008.04.27 |
申请号 |
RU19960111958 |
申请日期 |
1996.06.19 |
申请人 |
TAKEDA FARMAS'JUTIKAL KOMPANI LIMITED |
发明人 |
IKEDA KHITOSI;SOKHDA TAKASI;ODAKA KHIROJUKI |
分类号 |
A61K45/06;A61K9/20;A61K9/48;A61K31/00;A61K31/133;A61K31/155;A61K31/18;A61K31/33;A61K31/41;A61K31/421;A61K31/4245;A61K31/425;A61K31/426;A61K31/44;A61K31/4439;A61K31/445;A61K31/52;A61K31/64;A61K31/70;A61K31/702;A61P3/08;A61P3/10;A61P5/50;A61P43/00;C07D233/54;C07D263/44;C07D277/20;C07D277/34 |
主分类号 |
A61K45/06 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|